+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Pertussis (Whooping Cough) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4768233
  • Report
  • April 2019
  • Region: Global
  • 185 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • BioNet- Asia Co Ltd
  • Cadila Healthcare Ltd
  • GlaxoSmithKline Plc
  • LG Chem Ltd
  • MCM Vaccine BV
  • Merck & Co Inc
  • MORE
The global clinical trial report- “2019 Pertussis (Whooping Cough) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Pertussis (Whooping Cough). It presents in-depth analysis of Pertussis (Whooping Cough) clinical trials across markets and companies. The research work is for providing complete understanding into trends in Pertussis (Whooping Cough).

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Pertussis (Whooping Cough) clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Pertussis (Whooping Cough)

The research work is prepared through extensive and continuous research on Pertussis (Whooping Cough) trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Pertussis (Whooping Cough) patients are identified
  • The report includes panorama of Pertussis (Whooping Cough) clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Pertussis (Whooping Cough) clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • BioNet- Asia Co Ltd
  • Cadila Healthcare Ltd
  • GlaxoSmithKline Plc
  • LG Chem Ltd
  • MCM Vaccine BV
  • Merck & Co Inc
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Pertussis (Whooping Cough) Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Pertussis (Whooping Cough) Clinical Trials by Region
2.2.2 Average Enrollment of Pertussis (Whooping Cough) Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Pertussis (Whooping Cough) Treatment, 2019

3. Region wise Pertussis (Whooping Cough) Clinical Trials
3.1 Asia Pacific Pertussis (Whooping Cough) Clinical Trials by Country
3.2 Europe Pertussis (Whooping Cough) Clinical Trials by Country
3.3 North America Pertussis (Whooping Cough) Clinical Trials by Country
3.4 Middle East and Africa Pertussis (Whooping Cough) Clinical Trials by Country
3.5 South and Central America Pertussis (Whooping Cough) Clinical Trials by Country

4. Pertussis (Whooping Cough) Clinical Trial Trends
4.1 Start Year wise Pertussis (Whooping Cough) Clinical Trials
4.2 Phase wise Pertussis (Whooping Cough) Clinical Trials
4.3 Trial Status wise Pertussis (Whooping Cough) Clinical Trials
4.4 Trial Type wise Pertussis (Whooping Cough) Clinical Trials

5. Pertussis (Whooping Cough) Average Enrollment Trends
5.1 Average Enrollment in Pertussis (Whooping Cough) Trials by Year
5.2 Average Enrollment in Pertussis (Whooping Cough) Trials by Phase
5.3 Average Enrollment in Pertussis (Whooping Cough) Trials by Status
5.4 Average Enrollment in Pertussis (Whooping Cough) Trials by Type of Trial

6. Companies Participating in Pertussis (Whooping Cough) Clinical Trials
6.1 Pertussis (Whooping Cough) Trials by Sponsor Type
6.2 Pertussis (Whooping Cough) Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Pertussis (Whooping Cough) Trials- Phase 1
7.2 Pertussis (Whooping Cough) Trials- Phase 2
7.3 Pertussis (Whooping Cough) Trials- Phase 3
7.4 Pertussis (Whooping Cough) Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Pertussis (Whooping Cough) Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Pertussis (Whooping Cough) Clinical Trials and Enrolment
Figure 5: Europe - Country wise Pertussis (Whooping Cough) Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Pertussis (Whooping Cough) Clinical Trials and Enrolment
Figure 7: North America - Country wise Pertussis (Whooping Cough) Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Pertussis (Whooping Cough) Clinical Trials and Enrolment
Figure 9: Pertussis (Whooping Cough) Clinical Trials by Phase
Figure 10: Pertussis (Whooping Cough) Clinical Trials by Trial Status
Figure 11: Pertussis (Whooping Cough) Clinical Trials by Type
Figure 12: Pertussis (Whooping Cough) Clinical Trials by Sponsor Type
Figure 13: Pertussis (Whooping Cough) Clinical Trials by Leading Sponsors
Figure 14: Pertussis (Whooping Cough) Average Enrollment by Phase
Figure 15: Pertussis (Whooping Cough) Average Enrollment by Trial Status
Figure 16: Pertussis (Whooping Cough) Average Enrollment by Type
Figure 17: Pertussis (Whooping Cough)- Average Enrolment by Type of Sponsors
Figure 18: Pertussis (Whooping Cough)- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Pertussis (Whooping Cough) Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Pertussis (Whooping Cough) Clinical Trials and Enrolment
Table 5: Europe - Country wise Pertussis (Whooping Cough) Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Pertussis (Whooping Cough) Clinical Trials and Enrolment
Table 7: North America - Country wise Pertussis (Whooping Cough) Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Pertussis (Whooping Cough) Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Pertussis (Whooping Cough) Average Enrollment by Phase
Table 15: Pertussis (Whooping Cough) Average Enrollment by Trial Status
Table 16: Pertussis (Whooping Cough) Average Enrollment by Type
Table 17: Pertussis (Whooping Cough)- Average Enrolment by Type of Sponsors
Table 18: Pertussis (Whooping Cough)- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • BioNet- Asia Co Ltd
  • Cadila Healthcare Ltd
  • GlaxoSmithKline Plc
  • LG Chem Ltd
  • MCM Vaccine BV
  • Merck & Co Inc
  • Novartis AG
  • Panacea Biotec Ltd
  • Sanofi
  • Serum Institute of India Ltd
Note: Product cover images may vary from those shown
Adroll
adroll